Your session is about to expire
← Back to Search
EndoBarrier Liner for Weight Loss (STEP-1 Trial)
Summary
This trial is testing the EndoBarrier System, a device placed in the stomach, to help people with Type 2 Diabetes and Obesity who haven't controlled their blood sugar well with current medications. The device works by reducing food absorption, aiding in better blood sugar control and weight loss. The EndoBarrier System has been shown to help with weight loss and better blood sugar control in patients with type 2 diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Trial Design
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery?Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes.
Find a Location
Screening: Screening visits will take 2 hours. During the screening visit, the trial will be reviewed by the study team and patients will be asked to sign a consent form if their questions have been answered and they would like to move forward with participating in the trial. Screening visits include:
- A review of medical history
- Measuring of weight
- Lab draw
- Urine and stool samples
Intervention: This is a double-blinded device study. Patients will be randomized on the day of the procedure and will undergo an endoscopy. Patients will not know which group they have been randomized to until the one year mark.
Follow-Up: Patients will be followed for a total of 2 years for this study. Follow-ups occur monthly for the first year and quarterly for the second year. Each study visit includes:
- Weight
- Waist and hip measurements
- Questions about current medical issues
- Lab draw
- Urine sample
- Ultrasound
The sponsor will compensate patients $50 per visit, up to $1,150 for the duration of the study if all visits are completed, to cover the cost of travel and parking.
Logistics
Travel, including flights, are covered
Your expenses for travel tickets for this trial will be reimbursed.
Who is running the clinical trial?
Media Library
- You are willing and able to follow all of the study rules.Your body weight is considered obese or severely obese according to your height.Women who could become pregnant must have a negative pregnancy test.My BMI is between 30 and 50.I have been diagnosed with type 2 diabetes for 15 years or less.Your HbA1c level is between 8.0% and 10%.I am not planning to get pregnant and will use approved birth control during the trial.I am taking or have taken medication for diabetes.My diabetes hasn't improved enough with two types of medication, excluding insulin.I have over a year's medical records available, including treatment details.My diabetes is not controlled with two medications, and I'm not on insulin.Your blood sugar level (HbA1c) is too high, between 8% and 10%.You have read and agreed to the information provided in the consent form.I am between 30 and 65 years old.I am not using insulin.I haven't taken weight loss drugs or lost 5% of my weight in the last 3 months.
- Group 1: Sham
- Group 2: EndoBarrier
- Screening: It may take up to 1 Weeks to process to see if you qualify in this trial.
- Treatment: You will receive the treatment for 24 Months
- Follow Ups: You may be asked to continue sharing information regarding the trial for 4 Weeks after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger